A Janus splicing regulatory element modulates HIV-1 tat and rev mRNA production by coordination of hnRNP A1 cooperative binding

Journal of Molecular Biology

Volumn 323, Issue 4, 2002, Pages 629-652

  Marchand, Virginie ^a   Méreau, Agnès ^a   Jacquenet, Sandrine ^a,c   Thomas, Denise ^a   Mougin, Annie ^a,d   Gattoni, Renata ^b   Stévenin, James ^b   Branlant, Christiane ^a  

^a Biopôle de l Université de Lorraine   (France)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^c CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

^d Université Paul Sabatier   (France)

Author keywords

ASF SF2; hnRNP A1; Splicing regulation; Tat protein; Virus HIV 1

Indexed keywords

MESSENGER RNA; RECOMBINANT PROTEIN; RNA; TRINUCLEOTIDE;

ARTICLE; BINDING AFFINITY; BINDING SITE; CROSS LINKING; ENHANCER REGION; ENZYMATIC ASSAY; GENE ACTIVITY; GENE CONTROL; GENE SEQUENCE; GENETIC PARAMETERS; HUMAN IMMUNODEFICIENCY VIRUS 1; NUCLEOTIDE SEQUENCE; OLIGOMERIZATION; PRIORITY JOURNAL; PURIFICATION; RNA ANALYSIS; RNA SPLICING; RNA STRUCTURE; RNA SYNTHESIS;

HUMAN IMMUNODEFICIENCY VIRUS 1; JANUS;

EID: 0036974666     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2836(02)00967-1     Document Type: Article

References (58)

1. Smith, C. W. & Valcarcel, J. (2000). Alternative pre-mRNA splicing: the logic of combinatorial control. Trends Biochem. Sci. 25, 381-388.
2. O'Reilly, M. M., McNally, M. T. & Beemon, K. L. (1995). Two strong 5′ splice sites and competing, suboptimal 3′ splice sites involved in alternative splicing of human immunodeficiency virus type 1 RNA. Virology, 213, 373-385.
3. Dyhr-Mikkelsen, H. & Kjems, J. (1995). Inefficient spliceosome assembly and abnormal branch site selection in splicing of an HIV-1 transcript in vitro. J. Biol. Chem. 270, 24060-24066.
4. Swanson, A. K. & Stoltzfus, C. M. (1998). Overlapping cis sites used for splicing of HIV-1 env/nef and rev mRNAs. J. Biol. Chem. 273, 34551-34557.
5. Staffa, A. & Cochrane, A. (1994). The tat/rev intron of human immunodeficiency virus type 1 is inefficiently spliced because of suboptimal signals in the 3′ splice site. J. Virol. 68, 3071-3079.
6. Staffa, A. & Cochrane, A. (1995). Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1. Mol. Cell. Biol. 15, 4597-4605.
7. Si, Z. H., Rauch, D. & Stoltzfus, C. M. (1998). The exon splicing silencer in human immunodeficiency virus type 1 Tat exon 3 is bipartite and acts early in spliceosome assembly. Mol. Cell. Biol. 18, 5404-5413.
8. Tange, T. O., Damgaard, C. K., Guth, S., Valcarcel, J. & Kjems, J. (2001). The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element. EMBO J. 20, 5748-5758.
9. Purcell, D. F. & Martin, M. A. (1993). Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J. Virol. 67, 6365-6378.
10. Karn, J. (1999). Tackling Tat. J. Mol. Biol. 293, 235-254. doi:10.1006/jmbi.1999.3060.
11. Boris-Lawrie, K., Roberts, T. M. & Hull, S. (2001). Retroviral RNA elements integrate components of post-transcriptional gene expression. Life Sci. 69, 2697-2709.
12. Bonavia, R., Bajetto, A., Barbero, S., Albini, A., Noonan, D. M. & Schettini, G. (2001). HIV-1 Tat causes apoptotic death and calcium homeostasis alterations in rat neurons. Biochem. Biophys. Res. Commun. 288, 301-308.
13. Li, C. J., Friedman, D. J., Wang, C., Metelev, V. & Pardee, A. B. (1995). Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science, 268, 429-431.
14. Piguet, V. & Trono, D. (2001). Living in oblivion: HIV immune evasion. Semin. Immunol. 13, 51-57.
15. Amendt, B. A., Si, Z. H. & Stoltzfus, C. M. (1995). Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors. Mol. Cell. Biol. 15, 4606-4615.
16. Caputi, M., Mayeda, A., Krainer, A. R. & Zahler, A. M. (1999). hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing. EMBO J. 18, 4060-4067.
17. Jacquenet, S., Mereau, A., Bilodeau, P. S., Damier, L., Stoltzfus, C. M. & Branlant, C. (2001). A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H. J. Biol. Chem. 276, 40464-40475.
18. Zhu, J., Mayeda, A. & Krainer, A. R. (2001). Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins. Mol. Cell, 8, 1351-1361.
19. Tange, T. O. & Kjems, J. (2001). SF2/ASF binds to a splicing enhancer in the third HIV-1 tat exon and stimulates U2AF binding independently of the RS domain. J. Mol. Biol. 312, 649-662. doi:10.1006/jmbi.2001.4971.
20. Hastings, M. L. & Krainer, A. R. (2001). Pre-mRNA splicing in the new millennium. Curr. Opin. Cell. Biol. 13, 302-309.
21. Valcarcel, J. & Green, M. R. (1996). The SR protein family: pleiotropic functions in pre-mRNA splicing. Trends Biochem. Sci. 21, 296-301.
22. Zhu, J. & Krainer, A. R. (2000). Pre-mRNA splicing in the absence of an SR protein RS domain. Genes Dev. 14, 3166-3178.
23. Mayeda, A., Screaton, G. R., Chandler, S. D., Fu, X. D. & Krainer, A. R. (1999). Substrate specificities of SR proteins in constitutive splicing are determined by their RNA recognition motifs and composite pre-mRNA exonic elements. Mol. Cell. Biol. 19, 1853-1863.
24. Fu, X. D., Mayeda, A., Maniatis, T. & Krainer, A. R. (1992). General splicing factors SF2 and SC35 have equivalent activities in vitro, and both affect alternative 5′ and 3′ splice site selection. Proc. Natl Acad. Sci. USA, 89, 11224-11228.
25. Gorlach, M., Burd, C. G., Portman, D. S. & Dreyfuss, G. (1993). The hnRNP proteins. Mol. Biol. Rep. 18, 73-78.
26. Bilodeau, P. S., Domsic, J. K., Mayeda, A., Krainer, A. R. & Stoltzfus, C. M. (2001). RNA splicing at human immunodeficiency virus type 1 3′ splice site A2 is regulated by binding of hnRNP A/B proteins to an exonic splicing silencer element. J. Virol. 75, 8487-8497.
27. Eperon, I. C., Makarova, O. V., Mayeda, A., Munroe, S. H., Caceres, J. F., Hayward, D. G. & Krainer, A. R. (2000). Selection of alternative 5′ splice sites: role of U1 snRNP and models for the antagonistic effects of SF2/ASF and hnRNP A1. Mol. Cell. Biol. 20, 8303-8318.
28. Mayeda, A. & Krainer, A. R. (1992). Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2. Cell, 68, 365-375.
29. Mayeda, A., Helfman, D. M. & Krainer, A. R. (1993). Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF. Mol. Cell. Biol. 13, 2993-3001.
30. Siebel, C. W., Kanaar, R. & Rio, D. C. (1994). Regulation of tissue-specific P-element pre-mRNA splicing requires the RNA-binding protein PSI. Genes Dev. 8, 1713-1725.
31. Blanchette, M. & Chabot, B. (1999). Modulation of exon skipping by high-affinity hnRNP A1-binding sites and by intron elements that repress splice site utilization. EMBO J. 18, 1939-1952.
32. Del Gatto, F., Plet, A., Gesnel, M. C., Fort, C. & Breathnach, R. (1997). Multiple interdependent sequence elements control splicing of a fibroblast growth factor receptor 2 alternative exon. Mol. Cell. Biol. 17, 5106-5116.
33. Hanamura, A., Caceres, J. F., Mayeda, A., Franza, B. R., Jr & Krainer, A. R. (1998). Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors. RNA, 4, 430-444.
34. Watakabe, A., Inoue, K., Sakamoto, H. & Shimura, Y. (1989). A secondary structure at the 3′ splice site affects the in vitro splicing reaction of mouse immunoglobulin μ chain pre-mRNAs. Nucl. Acids Res. 17, 8159-8169.
35. Mougin, A., Gregoire, A., Banroques, J., Segault, V., Fournier, R., Brule, F. et al. (1996). Secondary structure of the yeast Saccharomyces cerevisiae pre-U3A snoRNA and its implication for splicing efficiency. RNA, 2, 1079-1093.
36. Libri, D., Piseri, A. & Fiszman, M. Y. (1991). Tissue-specific splicing in vivo of the beta-tropomyosin gene: dependence on an RNA secondary structure. Science, 252, 1842-1845.
37. Muro, A. F., Caputi, M., Pariyarath, R., Pagani, F., Buratti, E. & Baralle, F. E. (1999). Regulation of fibronectin EDA exon alternative splicing: possible role of RNA secondary structure for enhancer display. Mol. Cell. Biol. 19, 2657-2671.
38. Jacquenet, S., Ropers, D., Bilodeau, P. S., Damier, L., Mougin, A., Stoltzfus, C. M. & Branlant, C. (2001). Conserved stem-loop structures in the HIV-1 RNA region containing the A3 3′ splice site and its cis-regulatory element: possible involvement in RNA splicing. Nucl. Acids Res. 29, 464-478.
39. Winkler, W. C., Grundy, F. J., Murphy, B. A. & Henkin, T. M. (2001). The GA motif: an RNA element common to bacterial antitermination systems, rRNA, and eukaryotic RNAs. RNA, 7, 1165-1172.
40. Klein, D. J., Schmeing, T. M., Moore, P. B. & Steitz, T. A. (2001). The kink-turn: a new RNA secondary structure motif. EMBO J. 20, 4214-4221.
41. Watkins, N. J., Segault, V., Charpentier, B., Nottrott, S., Fabrizio, P., Bachi, A. et al. (2000). A common core RNP structure shared between the small nucleoar box C/D RNPs and the spliceosomal U4 snRNP. Cell, 103, 457-466.
42. Burd, C. G. & Dreyfuss, G. (1994). RNA binding specificity of hnRNP A1: significance of hnRNP A1 high-affinity binding sites in pre-mRNA splicing. EMBO J. 13, 1197-1204.
43. Tacke, R. & Manley, J. L. (1995). The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities. EMBO J. 14, 3540-3551.
44. Cavaloc, Y., Bourgeois, C. F., Kister, L. & Stevenin, J. (1999). The splicing factors 9G8 and SRp20 transactivate splicing through different and specific enhancers. RNA, 5, 468-483.
45. Muhlemann, O., Yue, B. G., Petersen-Mahrt, S. & Akusjarvi, G. (2000). A novel type of splicing enhancer regulating adenovirus pre-mRNA splicing. Mol. Cell. Biol. 20, 2317-2325.
46. Duc Dodon, M., Hamaia, S., Martin, J. & Gazzolo, L. (2002). Heterogeneous nuclear ribonucleoprotein A1 interferes with the binding of the human T cell leukemia virus type 1 Rex regulatory protein to its response element. J. Biol. Chem. 277, 18744-18752.
47. Pongoski, J., Asai, K. & Cochrane, A. (2002). Positive and negative modulation of human immunodeficiency virus type 1 Rev function by cis and trans regulators of viral RNA splicing. J. Virol. 76, 5108-5120.
48. Peloponese, J. M., Jr, Collette, Y., Gregoire, C., Bailly, C., Campese, D., Meurs, E. F. et al. (1999). Full peptide synthesis, purification, and characterization of six Tat variants. Differences observed between HIV-1 isolates from Africa and other continents. J. Biol. Chem. 274, 11473-11478.
49. Charneau, P., Alizon, M. & Clavel, F. (1992). A second origin of DNA plus-strand synthesis is required for optimal human immunodeficiency virus replication. J. Virol. 66, 2814-2820.
50. Nour, M., Naimi, A., Beck, G. & Branlant, C. (1995). 16S-23S and 23S-5S intergenic spacer regions of Streptococcus thermophilus and Streptococcus salivarius, primary and secondary structure. Curr. Microbiol. 31, 270-278.
51. Ratner, L., Haseltine, W., Patarca, R., Livak, K. J., Starcich, B., Josephs, S. F. et al. (1985). Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature, 313, 277-284.
52. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual, 2nd edit., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
53. Damier, L., Domenjoud, L. & Branlant, C. (1997). The D1-A2 and D2-A2 pairs of splice sites from human immunodeficiency virus type 1 are highly efficient in vitro, in spite of an unusual branch site. Biochem. Biophys. Res. Commun. 237, 182-187.
54. England, T., Bruce, A. & Uhlenbeck, O. (1980). Specific labeling of 3′ termini of RNA with T4 ligase. Methods Enzymol. 65, 65-74.
55. Vassilenko, S. K. & Babkina, G. T. (1965). Isolation and properties of ribonuclease isolated from cobra venom. Biokhymiya, 30, 705-712.
56. Jaeger, J. A., Turner, D. H. & Zuker, M. (1989). Improved predictions of secondary structures for RNA. Proc. Natl Acad. Sci. USA, 86, 7706-7710.
57. Portman, D. S. & Dreyfuss, G. (1994). RNA annealing activities in HeLa nuclei. EMBO J. 13, 213-221.
58. Thompson, J. D., Higgins, D. G. & Gibson, T. J. (1994). CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucl. Acids Res. 22, 4673-4680.